Navigation Links
Avisena Announces Major Increases in Profit for Second Quarter 2009
Date:8/18/2009

Revenue Cycle Management Specialists, Avisena, Announces Increased Earnings for the Second Quarter, Including Positive Operating Profit for the Year-to-Date.

Miami, FL (PRWEB) August 18, 2009 -- Avisena, Inc., a revenue cycle management (RCM) company servicing the health care industry that offers a proprietary, Internet-based technology platform, announced strong second quarter results driven by a growing demand in healthcare practice management solutions. Avisena cites consistent sales productivity, technology enhancements as well as operational improvements as the reason for the companies continued financial success.

Operating profit was up 148 percent compared to the same quarter in 2008. Avisena continues to thrive in the midst of a struggling US (Global) economy and is well on track to deliver an eighth consecutive year of steady financial growth.

"Even in these economically difficult times, Avisena is continually hiring and creating opportunities in the communities we do business; we also are increasing shareholder value by steady growth and projected increases in revenue," said Mike Maseda, Avisena President and CEO. "Avisena has experienced a 20 percent growth in year-to-date claims revenue from '08 to '09. These metrics can be attributed to our continued innovation, relentless focus on client service, and superior client collection results," explained Maseda.

According to the Medical Group Management Association 73 percent of practices are dealing with operating costs that are rising more rapidly than revenue. Traditionally run medical practices are being squeezed by increasing cost pressure coupled with declining payer reimbursement resulting in significant reduction in profits. In order to combat these on-going trends, practices are turning to Avisena's Software Enabled Service (SES) model for more efficient and cost effective solutions to reduce expenses and increase revenues.

"Physicians are asking how they can save money and do more with decreasing revenue," said Maseda. "Avisena is uniquely positioned to help our customers save money by offering advanced technologies that will help physicians streamline the payer reimbursement process. It is commonplace for Avisena clients to experience 10% to 20% revenue growth while simultaneously reducing their expenses to their bottom-line."

In addition to notable increase in profits, Q2 presented Avisena with national recognition for its economic consistency and growth in recent years. Accolades include ranking as the 1,018 fastest-growing company in Inc 500/5000 2009 list as well as local recognition as the Greater Miami Chamber of Commerce's "Good to Great Business in the 51-249 employee category" and the South Florida Business Journal "Business of the Year."

About Avisena:
Avisena is a revenue cycle management company that helps medical practices improve collections through the use of its Internet-based medical billing software technology and practice management expertise. By streamlining front and back office processes, Avisena helps medical practices Collect More, Spend Less and Live Better. Visit Avisena online at http://www.avisena.com.

# # #

Read the full story at http://www.prweb.com/releases/revenuecyclemanagement/avisena/prweb2748704.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. Simcere Pharmaceutical Group Reports Unaudited Second Quarter 2009 Results and Announces Share Repurchase
2. Accelify Announces Training Dates for Missouri Medicaid Consortium
3. Wyeth Announces Full Redemption of Floating Rate Convertible Senior Debentures Due 2024
4. Gaiam Announces New Deal With Valerie Bertinelli
5. MHA Announces Gloria Barr, Esq. as Vice President & General Counsel
6. LifeCare Holdings, Inc. Announces Second Quarter Results
7. Secretary Shinseki Announces Expansion of Counseling for Combat Veterans
8. China-Biotics, Inc. Announces Conference Call to Discuss First Quarter Fiscal 2010 Financial Results
9. Purple Communications(TM) Announces Second Quarter 2009 Results
10. Video: Schering-Plough Announces FDA Approval of SAPHRIS(R) (asenapine) for Acute Treatment of Schizophrenia In Adults and Manic or Mixed Episodes of Bipolar I Disorder With or Without Psychotic Features In Adults
11. Centrix Pharmaceutical Announces Clofera(TM), a Unique Antitussive and Nasal Decongestant for the Temporary Relief of Cough and Nasal Congestion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... ... January 23, 2017 , ... ... in North America for the scientific development, healthcare training and clinical application of ... and its 2017 AAT Member Certification Qualification Courses for Technicians, respectively. , For ...
(Date:1/23/2017)... ... January 23, 2017 , ... "ProRandom is a set of camera tools that allow video editors ... Final Cut Pro X," said Christina Austin - CEO of Pixel Film Studios. , ... text with video footage. ProRandom works by using a virtual camera to create the ...
(Date:1/23/2017)... ... January 23, 2017 , ... “Crossing the Bar”: ... minutes of a woman’s life. “Crossing the Bar” is the creation of published author, ... children. , Charlotte, who credits the inspiration of the book to her sister, ...
(Date:1/22/2017)... MALO, FRANCE (PRWEB) , ... January 22, 2017 , ... ... Indian Ocean, isolated from the rest of the world with ZANZIBAR MILKY CREAM. Inspired ... Phytocéane used key ingredients like Virgin Coconut Oil and moisturizing vegetal coral to create ...
(Date:1/21/2017)... ... 21, 2017 , ... Salveo for life, a company that distributes an effervescent ... United States as part of its presence to expand its market reach. , Using ... the productions of nasty toxins as a result of drinking alcohol, eliminating those toxins ...
Breaking Medicine News(10 mins):
(Date:1/23/2017)... SAN DIEGO , 23 janvier 2017  ResMed ... Winter Haven , Floride) ont annoncé aujourd,hui qu,ils se ... les litiges existants entre les parties. BMC et 3B ... de paiements de droits à ResMed, et ResMed effectuera ... à 3B pour clore le litige de Floride entre ...
(Date:1/23/2017)... and PALMA, Spain , January ... S.L., a clinical-stage biopharmaceutical company focused on treatments ... patient has been enrolled in the Phase IIb ... for the treatment of cardiovascular calcification (CVC) in ... Most ESRD patients, in the last stage of ...
(Date:1/23/2017)... 2017 InDex Pharmaceuticals Holding AB (publ) today ... congress of the European Crohn,s and Colitis Organisation (ECCO). The ECCO ... focus on inflammatory bowel disease (IBD). The congress is held in ... ... to again having been selected to present data at the largest ...
Breaking Medicine Technology: